United States Securities and Exchange Commission · EDGAR Accession 0001429819-25-000003

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 1429819
Raising via StartEngine Primary, LLC

Calosyn Pharma, Inc.

CorporationDEIncorporated 2007Shreveport, LAcalosyn.com
A

The Offering

as disclosed in this filing
Other (Convertible Note)
$20,000
$1,235,000
December 29, 2025
Expired 167 days ago
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn decreasingDebt / assets 1704%3 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(637,680)(767,511)▲ burn
Total assets164,279154,570▲ 6%
Cash & equivalents147,320136,426▲ 8%
Accounts receivable00
Short-term debt436,182348,029▲ 25%
Long-term debt2,363,2471,817,403▲ 30%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.